Publication
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results.
Journal Paper/Review - Jun 13, 2024
Gantenbein Andreas R, Bonvin Christophe, Kamm Christian Philipp, Schankin Christoph J, Zecca Chiara, Zieglgänsberger Dominik, Merki-Feld Gabriele Susanne, Pohl Heiko, Rudolph Nicole, Ryvlin Philippe, Agosti Reto, Schäfer Elisabeth, Meyer Ina, Kulartz-Schank Monika, Arzt Michael E
Gantenbein, Andreas R
2
0
Bonvin, Christophe
8
0
Kamm, Christian Philipp
2
0
Schankin, Christoph J
1
0
Zecca, Chiara
8
0
Zieglgänsberger, Dominik
Neurologie · Dept. III
8
2
Merki-Feld, Gabriele Susanne
Pohl, Heiko
1
0
Rudolph, Nicole
Ryvlin, Philippe
Agosti, Reto
1
0